Literature DB >> 19120476

Approaching the RNA ligand for RIG-I?

Martin Schlee1, Evelyn Hartmann, Christoph Coch, Vera Wimmenauer, Markus Janke, Winfried Barchet, Gunther Hartmann.   

Abstract

Innate and antigen-specific antiviral immunity are triggered by immunorecognition of viral nucleic acids. The helicase retinoic acid-inducible gene I (RIG-I) (also known as DDX58) is the key sensor of negative strand RNA viruses in the cytosol of cells. RNA containing a triphosphate at the 5'-end was shown to activate RIG-I, but the exact structure of RNA supporting 5'-triphosphate recognition, the requirement of a 5'-triphosphate group, as well as the existence of RNA structures detected by RIG-I in the absence of 5'-triphosphate remain controversial. Here, we revisit the literature on RIG-I and RIG-I ligands. The literature proposes at least six different RIG-I ligands: (i) single strand with a 5'-triphosphate, (ii) double-stranded RNA with a 5'-triphosphate, (iii) 5'-triphosphate single-stranded RNA with A- and U-rich 3'-sequences, (iv) double-stranded RNA of intermediate length (>300 and <2000 bp) without 5'-triphosphate, (v) blunt-end short double-stranded RNA (23-30 bp) without 5'-triphosphate, and (vi) short double-stranded RNA (23-30 bp) with 5'-monophosphate. RIG-I thus seems promiscuous for a variety of different RNA molecules, very similar to the Toll-like receptors, of which 10 family members are sufficient for the safe detection of the microbial cosmos. In the light of these outstanding publications, it seems an unlikely possibility that there is a fundamental shortcoming in the design of all studies. Looking closely, the only issue that comes to mind is the in vitro transcription technique used by all investigators without confirming the identity of RNA products. This technique, together with the different biological systems used, the lack of dose responses and of proper comparison of different published ligands and controls leave us with more questions than answers as to what the exact RIG-I ligand is, if in fact it exists.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19120476     DOI: 10.1111/j.1600-065X.2008.00724.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  44 in total

1.  Listeria monocytogenes strain-specific impairment of the TetR regulator underlies the drastic increase in cyclic di-AMP secretion and beta interferon-inducing ability.

Authors:  Takeshi Yamamoto; Hideki Hara; Kohsuke Tsuchiya; Shunsuke Sakai; Rendong Fang; Motohiro Matsuura; Takamasa Nomura; Fumihiko Sato; Masao Mitsuyama; Ikuo Kawamura
Journal:  Infect Immun       Date:  2012-04-16       Impact factor: 3.441

2.  Structural basis of RNA recognition and activation by innate immune receptor RIG-I.

Authors:  Fuguo Jiang; Anand Ramanathan; Matthew T Miller; Guo-Qing Tang; Michael Gale; Smita S Patel; Joseph Marcotrigiano
Journal:  Nature       Date:  2011-09-25       Impact factor: 49.962

3.  Ebolavirus VP35 is a multifunctional virulence factor.

Authors:  Daisy W Leung; Kathleen C Prins; Christopher F Basler; Gaya K Amarasinghe
Journal:  Virulence       Date:  2010-11-01       Impact factor: 5.882

Review 4.  Cell-intrinsic innate immune control of West Nile virus infection.

Authors:  Michael S Diamond; Michael Gale
Journal:  Trends Immunol       Date:  2012-06-20       Impact factor: 16.687

5.  5'-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I.

Authors:  Andreas Schmidt; Tobias Schwerd; Wolfgang Hamm; Johannes C Hellmuth; Sheng Cui; Michael Wenzel; Franziska S Hoffmann; Marie-Cecile Michallet; Robert Besch; Karl-Peter Hopfner; Stefan Endres; Simon Rothenfusser
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-02       Impact factor: 11.205

6.  Autophagy links pattern recognition receptors to tumor cell apoptosis.

Authors:  Jörg Vollmer
Journal:  Mol Ther       Date:  2009-11       Impact factor: 11.454

Review 7.  Sensors of the innate immune system: their mode of action.

Authors:  Roberto Baccala; Rosana Gonzalez-Quintial; Brian R Lawson; Michael E Stern; Dwight H Kono; Bruce Beutler; Argyrios N Theofilopoulos
Journal:  Nat Rev Rheumatol       Date:  2009-07-14       Impact factor: 20.543

8.  Mouse embryonic stem cells have underdeveloped antiviral mechanisms that can be exploited for the development of mRNA-mediated gene expression strategy.

Authors:  Ruoxing Wang; Chengwen Teng; Joseph Spangler; Jundi Wang; Faqing Huang; Yan-Lin Guo
Journal:  Stem Cells Dev       Date:  2013-12-20       Impact factor: 3.272

9.  Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35.

Authors:  Daisy W Leung; Kathleen C Prins; Dominika M Borek; Mina Farahbakhsh; JoAnn M Tufariello; Parameshwaran Ramanan; Jay C Nix; Luke A Helgeson; Zbyszek Otwinowski; Richard B Honzatko; Christopher F Basler; Gaya K Amarasinghe
Journal:  Nat Struct Mol Biol       Date:  2010-01-17       Impact factor: 15.369

10.  Study of human RIG-I polymorphisms identifies two variants with an opposite impact on the antiviral immune response.

Authors:  Julien Pothlichet; Anne Burtey; Andriy V Kubarenko; Gregory Caignard; Brigitte Solhonne; Frédéric Tangy; Meriem Ben-Ali; Lluis Quintana-Murci; Andrea Heinzmann; Jean-Daniel Chiche; Pierre-Olivier Vidalain; Alexander N R Weber; Michel Chignard; Mustapha Si-Tahar
Journal:  PLoS One       Date:  2009-10-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.